NEW YORK, November 7, 2014 /PRNewswire/ --
Today, Analysts Review released its research reports regarding Eastman Chemical Co. (NYSE: EMN), American Express Company (NYSE: AXP), Itau Unibanco Holding S.A. (NYSE: ITUB), Marsh & McLennan Companies, Inc. (NYSE: MMC) and ACE Limited (NYSE: ACE). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7773-100free.
--
Eastman Chemical Co. Research Reports
On October 30, 2014, Eastman Chemical Co. (Eastman Chemical) announced its Q3 2014 financial results. The Company said that its revenue during the quarter increased 3.2% YoY to $2.4 billion, which were in-line with Reuters' consensus estimates. Net income attributable to Company shareholders fell to $210 million, or $1.39 per diluted share, compared to $308 million, or $1.97 per diluted share, in Q3 2013. Excluding non-core or non-recurring items, the Company said that it earned $1.89 per diluted share in Q3 2014, up from $1.68 per diluted share in Q3 2013, besides beating the average estimates of $1.80 per share in a Reuters' poll. Eastman Chemical's Chairman and CEO Mark Costa said, "During the fourth quarter, we expect strong results as demand remains solid with normal seasonality, product mix improvement continues, and raw material and energy costs are a tailwind. We therefore expect 2014 earnings per share to approach $7, delivering our fifth consecutive year of earnings growth." The full research reports on Eastman Chemical are available to download free of charge at:
http://www.analystsreview.com/Nov-07-2014/EMN/report.pdf
--
American Express Company Research Reports
On November 3, 2014, American Express Company (American Express) announced the launch of its American Express Token Service, which replaces traditional card account numbers with unique "tokens" with an aim to create a safer online and mobile payments environment for consumers. According to the Company, the unique tokens can be used to complete the payment transactions online, in a mobile app or in-store with a mobile NFC-enabled device, without requiring merchants and digital wallet operators to store consumers' sensitive payment account information in their systems. In addition, tokens can be assigned for use with a specific merchant, transaction type or payment device to provide further protection against fraud. The service is available in the U.S., and international rollout is expected to begin in 2015. The full research reports on American Express are available to download free of charge at:
http://www.analystsreview.com/Nov-07-2014/AXP/report.pdf
--
Itau Unibanco Holding S.A. Research Reports
On November 4, 2014, Itau Unibanco Holding S.A. (Itau Unibanco), Brazil's second largest bank by assets, announced its Q3 2014 financial results. The Company reported net income for the quarter at R$5.4 billion, up 35.3% YoY. Recurring net income was R$5.5 billion, beating the Reuters poll estimate of R$5.029 billion. In Q3 2014, Itau Unibanco's operating revenues totaled R$23.3 billion, an increase of 18.8% YoY. The Company's managerial financial margin with clients, which arises from the use of financial products by its clients, totaled R$13.3 billion, corresponding to a 4.5% increase from the previous quarter, helped mainly by the increase in the margin of SELIC rate-sensitive operations, to the higher volume of loan operations and the early termination of the agreement between Itaú Seguros S.A. and Via Varejo in the current quarter. Itau Unibanco's ADRs gained 1.78% to close at $14.83. The full research reports on Itau Unibanco are available to download free of charge at:
http://www.analystsreview.com/Nov-07-2014/ITUB/report.pdf
--
Marsh & McLennan Companies, Inc. Research Reports
On October 28, 2014, Marsh & McLennan Companies, Inc. (Marsh & McLennan) announced its Q3 2014 financial results. The Company's revenue for the quarter increased 7.1% YoY to $3.1 billion. During the quarter, Risk and Insurance Services revenue of the Company increased 7.0% YoY to $1.6 billion and Consulting revenue increased 7.2% YoY to $1.5 billion. Net income attributable to the Company was $297 million, or $0.54 per diluted share, compared to $253 million, or $0.45 per diluted share, in the year ago period. On an adjusted basis, the Company's net income per share stood at $0.56, beating the average estimate of $0.52 in a Reuters' analysts' poll. Marsh & McLennan's President and CEO, Dan Glaser said, "The Company delivered its thirteenth consecutive quarter of double-digit growth in adjusted earnings per share." The full research reports on Marsh & McLennan are available to download free of charge at:
http://www.analystsreview.com/Nov-07-2014/MMC/report.pdf
--
ACE Limited Research Reports
On October 26, 2014, ACE Limited (ACE) announced the appointment of Edward Ler as the new President Director for Indonesia's general insurance business. In his new role, Edward will report to Juan Luis Ortega, Regional President for ACE in Asia Pacific. Commenting on the appointment, Ortega said, "With Indonesia as a strategic growth country for ACE Group, Edward's depth and breadth of insurance industry experience will be well tapped." The full research reports on ACE are available to download free of charge at:
http://www.analystsreview.com/Nov-07-2014/ACE/report.pdf
--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
